T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapse-Reference-Cited by-同舟云学术

T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapse

Published:2010-12-10 Issue:2 Volume:52 Page:214-222
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Kenkre Vaishalee P.,Horowitz Sarah,Artz Andrew S.,Liao Chuanhong,Cohen Kenneth S.,Godley Lucy A.,Kline Justin P.,Smith Sonali M.,Stock Wendy,van Besien Koen

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2010.538777

Reference31 articles.

1. Impact of Pre-transplant Rituximab on Survival after Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B Cell Lymphoma

2. Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma

3. Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

4. In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequential intensive chemotherapy followed by autologous or allogeneic transplantation for refractory lymphoma;Leukemia & Lymphoma;2021-02-13

2. Ex vivo T-cell–depleted allogeneic stem cell transplantation for hematologic malignancies: The search for an optimum transplant T-cell dose and T-cell add-back strategy;Cytotherapy;2017-06

3. Allografting versus Autografting for Follicular Lymphoma: An Ongoing Conundrum;Biology of Blood and Marrow Transplantation;2015-12

4. Stem cell transplantation in follicular lymphoma;Clinical Guide to Transplantation in Lymphoma;2015-05-15

5. A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies;Leukemia & Lymphoma;2014-03-20